Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

American CryoStem Announces "ACS Laboratory Services"

Published: Friday, January 13, 2012
Last Updated: Friday, January 13, 2012
Bookmark and Share
This new branding reflects the company's increasing commercialization of products and services developed for its proprietary clinical tissue processing methodologies.

CryoStem have begun offering the first of these products for sale and license which are based on their granted patent (Cell Culture Media, Kits and Methods of Use," (US 7,898,205 B2)). The product line is the first patented culture, growth and differentiation media specifically designed for use with adipose derived stem cells (ADSC) and is ideally suited for the conversion of new ADSC therapies from research to clinical application. The media is available in both research and clinical grade, in 100ml to 1 liter ready to use quantities. The product line includes undifferentiated growth media, and adipogenic, chondrogenic, and osteogenic differentiation media. The clinical grade media are free from animal (xenomorphic) serum and additives which make them ideally suited for the expansion and differentiation of ADSCs intended for clinical use.

The company made their first commercial sale of our media products this month and have begun marketing to increase industry recognition and sales. They currently have a new website www.acslaboratories.com under construction to support this new product offering and all future products and services commercialized by ACS Laboratories.

David Moscatello, Chief Scientist, stated, "I am very excited to have begun offering these products to my colleagues working with ADSCs and believe that these products will assist them in the acceleration of their treatment development. We have additional products and services in various stages of development based on our patented technologies and core adipose tissue processing platform that will be unveiled during the coming year."

John S. Arnone, CEO, stated, "We are very enthusiastic to be able to announce the commercialization and initial sales revenue from products developed from our recently issued patent. During 2011 we have been the beneficiary of increased dialogue and involvement from both doctors and researchers regarding our services and products under development. Our overall philosophy concerning the services offered by ACS Laboratories is to offer clinical grade products that are free from animal materials that can relieve some of the costs and the significant and increasing regulatory burdens for developers of cellular technologies. These burdens are evidenced in the U.S. Department of Health and Human Services and the FDA's regulations and guidance for manufacturers and developers in relation to the inclusion of xenomorphic (animal) material in the manufacturing and marketing of new and existing cellular products."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mitochondria Shown to Trigger Cell Ageing
An international team of scientists has for the first time shown that mitochondria, the batteries of the cells, are essential for ageing.
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Editing of Embryos Approved in the UK
The Human Fertilisation and Embryology Authority (HFEA) has approved a research application from the Francis Crick Institute to use new "gene editing" techniques on human embryos.
Microbes Take Their Vitamins
Scientists exploit organisms' needs in order to track 'vitamin mimics' in bacteria.
Machine Learning Uncovers Unknown Bacterial Features
Technique robustly identified characteristic gene expression patterns in response to antibiotics, low oxygen conditions.
CRISPR-Cas9 Gene Editing Advances Again
UC Berkeley researchers have made a major improvement in CRISPR-Cas9 technology that achieves an unprecedented success rate of 60 percent when replacing a short stretch of DNA with another.
Disrupting Cell’s Supply Chain Freezes Cancer Virus
When the cancer-causing Epstein-Barr virus moves into a B-cell of the human immune system, it tricks the cell into rapidly making more copies of itself, each of which will carry the virus.
Why Do Some Infections Persist?
In preparing for the possibility of an antibiotic onslaught, some bacterial cultures adopt an all-for-one/one-for-all strategy that would make a socialist proud, University of Vermont researchers have found.
ASCB: A CELLebration of Cell Biology
The last major congress of the year, ASCB is less a platform for launching new products, but one for confirming and consolidating the trends that have emerged over the past 12 months.
Squeezing Cells into Stem Cells
EPFL scientists have developed a new method that helps cells turn in usable stem cells. The new approach involves “squeezing” cells with a gel, and paves the way for large-scale production of stem cells for medical purposes.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!